Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Moderna Just Gave Investors 499 Million Reasons to Worry


Moderna (NASDAQ: MRNA) announced its second-quarter results before the market opened on Wednesday. And it easily beat Wall Street's expectations.

The vaccine maker reported Q2 revenue of $4.7 billion, up nearly 7% year over year and higher than the consensus estimate of $4.07 billion. Moderna posted earnings per share of $5.24, well above the average analysts' estimate of $4.55. 

With these positive numbers, the vaccine stock unsurprisingly jumped around 16% in early trading on Wednesday. But Moderna also just gave investors 499 million reasons to worry.

Continue reading


Source Fool.com

Like: 0
Share

Comments